WallStSmart

Scworx Corp (WORX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Scworx Corp stock (WORX) is currently trading at $0.13. Scworx Corp PS ratio (Price-to-Sales) is 0.72. WallStSmart rates WORX as Sell.

  • WORX PE ratio analysis and historical PE chart
  • WORX PS ratio (Price-to-Sales) history and trend
  • WORX intrinsic value — DCF, Graham Number, EPV models
  • WORX stock price prediction 2025 2026 2027 2028 2029 2030
  • WORX fair value vs current price
  • WORX insider transactions and insider buying
  • Is WORX undervalued or overvalued?
  • Scworx Corp financial analysis — revenue, earnings, cash flow
  • WORX Piotroski F-Score and Altman Z-Score
  • WORX analyst price target and Smart Rating
WORX

Scworx Corp

NASDAQHEALTHCARE
$0.13
$0.00 (1.50%)
52W$0.11
$1.37

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Scworx Corp (WORX) · 8 metrics scored

Smart Score

29
out of 100
Grade: F
Avoid
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.

Scworx Corp (WORX) Key Strengths (2)

Avg Score: 10.0/10
Price/SalesValuation
0.7210/10

Paying less than $1 for every $1 of annual revenue

Price/BookValuation
0.3410/10

Trading below book value, meaning the market prices it less than net assets

Supporting Valuation Data

Price/Sales (TTM)
0.721
Undervalued
EV/Revenue
0.482
Undervalued

Scworx Corp (WORX) Areas to Watch (6)

Avg Score: 0.8/10
Return on EquityProfitability
-74.20%0/10

Company is destroying shareholder value

Operating MarginProfitability
-19.70%0/10

Losing money on operations

Revenue GrowthGrowth
-7.10%0/10

Revenue declining -7.10%, a shrinking business

Profit MarginProfitability
-139.70%0/10

Company is losing money with a negative profit margin

Institutional Own.Quality
3.01%2/10

Very low institutional interest at 3.01%

Market CapQuality
$2M3/10

Micro-cap company with very limited liquidity and high volatility

Scworx Corp (WORX) Detailed Analysis Report

Overall Assessment

This company scores 29/100 in our Smart Analysis, earning a F grade. Out of 8 metrics analyzed, 2 register as strengths (avg 10.0/10) while 6 fall into concern territory (avg 0.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Price/Book. Valuation metrics including Price/Sales (0.72), Price/Book (0.34) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Return on Equity, Operating Margin, Revenue Growth. Growth concerns include Revenue Growth at -7.10%, which may limit upside. Profitability pressure is visible in Return on Equity at -74.20%, Operating Margin at -19.70%, Profit Margin at -139.70%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -74.20% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -7.10% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

WORX Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

WORX's Price-to-Sales ratio of 0.72x trades at a deep discount to its historical average of 52.81x (2th percentile). The current valuation is 100% below its historical high of 752.91x set in Mar 2019, and 14% above its historical low of 0.63x in Dec 2018. Over the past 12 months, the PS ratio has compressed from ~4.0x as trailing revenue scaled faster than the stock price.

Compare WORX with Competitors

Top HEALTH INFORMATION SERVICES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Scworx Corp (WORX) · HEALTHCAREHEALTH INFORMATION SERVICES

The Big Picture

Scworx Corp is in a turnaround phase, with management focused on restoring profitability. Revenue reached 3M with 7% decline year-over-year. The company is currently unprofitable, posting a -139.7% profit margin.

Key Findings

Low Leverage

Debt-to-equity ratio of 0.00 indicates a conservative balance sheet with 684,295 in cash.

Revenue Decline

Revenue contracted 7% YoY. Worth determining whether this is cyclical or structural.

Operating at a Loss

The company is unprofitable with a -139.7% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Volatility is elevated with a beta of 2.02, so expect amplified moves relative to the broader market.

Sector dynamics: monitor HEALTH INFORMATION SERVICES industry trends, competitive moves, and regulatory changes that could impact Scworx Corp.

Bottom Line

Scworx Corp is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Scworx Corp(WORX)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

HEALTH INFORMATION SERVICES

Country

USA

Scworx Corp (WORX) is a leading provider of advanced healthcare data solutions, focused on streamlining clinical data and insights for healthcare providers and stakeholders. Leveraging innovative technology, Scworx enhances operational efficiency and elevates care quality, enabling institutions to make data-driven decisions through comprehensive analytics. The company's strategic emphasis on scalability and innovation positions it well to address the increasing demand for data-centric solutions in the healthcare sector, ultimately driving improved patient outcomes and fostering effective cost management strategies. Scworx's commitment to transforming healthcare delivery underscores its pivotal role in a rapidly evolving market landscape.

Visit Scworx Corp (WORX) Website
100 S ASHLEY DR, TAMPA, FL, UNITED STATES, 33602